Ovarian Cancer Clinical Trials

Find Ovarian Cancer Clinical Trials Near You

WellSpan Study of Tracking Health and Resilience to Improve the Vitality of Individuals Experiencing Cancer [WellSpan-THRIVE]

Status: Recruiting
Location: See all (5) locations...
Study Type: Observational
SUMMARY

Cancer affects millions of people worldwide and can significantly impact not only survival, but also day-to-day quality of life. Treatments such as surgery, chemotherapy, and radiation can cause side effects like fatigue, pain, and neuropathy, which may affect physical function, emotional well-being, and social relationships. While many studies have examined factors that influence quality of life; such as age, type and stage of cancer, and treatment-related symptoms; there is still a need for tools that more fully reflect patients' lived experiences. This study aims to develop and implement a patient-centered quality of life (QOL) survey designed specifically for individuals with cancer. By directly involving patients in sharing what matters most to them, the survey seeks to provide a more complete and accurate understanding of how cancer and its treatment affect daily life. The results will help patients, families, and healthcare providers better identify needs, guide supportive care, and improve overall well-being throughout the cancer journey.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age 18 years and above

• Primary cancer diagnosis (newly diagnosed within the past 6 months)

• Able to sign informed consent.

Locations
United States
Pennsylvania
WellSpan Medical Oncology & Hematology
RECRUITING
Chambersburg
WellSpan Ephrata Cancer Center
RECRUITING
Ephrata
WellSpan Adams Cancer Center
RECRUITING
Gettysburg
WellSpan Sechler Family Cancer Center
RECRUITING
Lebanon
WellSpan York Cancer Center
RECRUITING
York
Contact Information
Primary
Joan K Moore, MSN, RN, OCN, CCRP
jmoore@wellspan.org
717-741-8124
Backup
Rahul Kashyap, MBBS, MBA, FCCM
rkashyap@wellspan.org
717-851-4611
Time Frame
Start Date: 2026-02
Estimated Completion Date: 2031-12
Participants
Target number of participants: 1000
Treatments
Patients Diagnosed with primary cancer in past 6 months
Patients Diagnosed with primary cancer in past 6 months will be divided into Race, ethnicity and gender and will be looked for differences in quality of life based on these subsets.
Related Therapeutic Areas
Sponsors
Leads: WellSpan Health

This content was sourced from clinicaltrials.gov